KeyNeurotek AG Strengthens Finance and Clinical Development Management
19-Jul-2006 -
KeyNeurotek AG, a biotechnology company focused on the development and marketing of drugs against degenerative disorders of the central nervous system (CNS) is announcing the enforcement of its management board. In addition to Dr. Frank Striggow (CEO), Hong Thieu has been appointed Chief ...
biotechnology
brain disorders
central nervous system
+2